摘要
目的探讨支气管动脉灌注化疗联合栓塞化疗治疗肺癌患者的临床效果。方法选取2017年1月至2020年4月我院收治的80例肺癌患者,随机分为两组各40例。对照组行支气管动脉灌注化疗,观察组行支气管动脉灌注化疗联合栓塞化疗,比较两组的治疗效果及不良反应。结果观察组的治疗总有效率为92.50%,显著高于对照组的72.50%(P<0.05)。两组的不良反应发生率比较,差异无统计学意义(P>0.05)。结论支气管动脉灌注化疗联合栓塞化疗治疗肺癌患者的效果显著,安全性高。
Objective To explore the clinical effect of bronchial artery infusion chemotherapy combined with embolization chemotherapy in the treatment of lung cancer.Methods 80 patients with lung cancer admitted to our hospital from January 2017 to April 2020 were selected and randomly divided into two groups,with 40 cases in each group.The control group received bronchial artery infusion chemotherapy,and the observation group received bronchial artery infusion chemotherapy combined with embolization chemotherapy.The therapeutic effects and adverse reactions of the two groups were compared.Results The total effective rate of treatment of the observation group was 92.50%,significantly higher than 72.50%of the control group(P<0.05).No statistical difference was found between the two groups in the incidence of adverse reactions(P>0.05).Conclusions Bronchial artery infusion chemotherapy combined with embolization chemotherapy in the treatment of patients with lung cancer has significant effect and high safety.
作者
鲁林鹏
丁铭明
张悦
LU Linpeng;DING Mingming;ZHANG Yue(Department of Oncology,Dengzhou Central Hospital,Nanyang 474150,China)
出处
《临床医学工程》
2021年第10期1373-1374,共2页
Clinical Medicine & Engineering
关键词
支气管动脉
灌注化疗
栓塞化疗
肺癌
不良反应
治疗效果
Bronchial artery
Infusion chemotherapy
Embolization chemotherapy
Lung cancer
Adverse reaction
Therapeutic effect
